The Arab Pesticides & Veterinary Drugs Mfg. Co. (ASE:MBED)
3.800
+0.020 (0.53%)
At close: Mar 4, 2026
ASE:MBED Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 35.88 | 35.71 | 29.94 | 24.24 | 22.63 | Upgrade
|
| Revenue Growth (YoY) | 0.49% | 19.27% | 23.51% | 7.12% | 0.29% | Upgrade
|
| Cost of Revenue | 23.31 | 23.83 | 20.16 | 15.96 | 14.64 | Upgrade
|
| Gross Profit | 12.57 | 11.88 | 9.78 | 8.28 | 7.98 | Upgrade
|
| Selling, General & Admin | 2.65 | 3.83 | 3.38 | 2.77 | 2.8 | Upgrade
|
| Other Operating Expenses | 1.95 | - | - | - | - | Upgrade
|
| Operating Expenses | 4.6 | 4.27 | 3.61 | 3.17 | 3.2 | Upgrade
|
| Operating Income | 7.97 | 7.61 | 6.17 | 5.11 | 4.79 | Upgrade
|
| Interest Expense | -0.45 | -0.33 | -0.29 | -0.23 | -0.28 | Upgrade
|
| Earnings From Equity Investments | - | 0.34 | 0.31 | 0.29 | 0.32 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.56 | 0.14 | 0.06 | 0.07 | 0.04 | Upgrade
|
| Pretax Income | 8.08 | 7.77 | 6.25 | 5.24 | 4.86 | Upgrade
|
| Income Tax Expense | 0.66 | 0.52 | 0.47 | 0.38 | 0.4 | Upgrade
|
| Earnings From Continuing Operations | 7.42 | 7.24 | 5.78 | 4.86 | 4.45 | Upgrade
|
| Minority Interest in Earnings | -1.38 | -1.54 | -1.3 | -0.95 | -0.91 | Upgrade
|
| Net Income | 6.04 | 5.7 | 4.47 | 3.91 | 3.55 | Upgrade
|
| Net Income to Common | 6.04 | 5.7 | 4.47 | 3.91 | 3.55 | Upgrade
|
| Net Income Growth | 5.93% | 27.44% | 14.44% | 10.17% | 6.71% | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 16 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 16 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | - | 6.45% | 3.33% | - | - | Upgrade
|
| EPS (Basic) | 0.37 | 0.35 | 0.29 | 0.26 | 0.24 | Upgrade
|
| EPS (Diluted) | 0.37 | 0.35 | 0.29 | 0.26 | 0.24 | Upgrade
|
| EPS Growth | 5.93% | 19.72% | 10.75% | 10.17% | 6.71% | Upgrade
|
| Free Cash Flow | - | 2.47 | -0.99 | 0.29 | 3.06 | Upgrade
|
| Free Cash Flow Per Share | - | 0.15 | -0.06 | 0.02 | 0.20 | Upgrade
|
| Dividend Per Share | 0.100 | 0.110 | 0.100 | 0.100 | 0.080 | Upgrade
|
| Dividend Growth | -9.09% | 10.00% | - | 25.00% | - | Upgrade
|
| Gross Margin | 35.04% | 33.27% | 32.66% | 34.17% | 35.29% | Upgrade
|
| Operating Margin | 22.22% | 21.32% | 20.61% | 21.10% | 21.15% | Upgrade
|
| Profit Margin | 16.83% | 15.96% | 14.94% | 16.12% | 15.68% | Upgrade
|
| Free Cash Flow Margin | - | 6.91% | -3.31% | 1.18% | 13.53% | Upgrade
|
| EBITDA | 8.47 | 8.15 | 6.67 | 5.58 | 5.19 | Upgrade
|
| EBITDA Margin | 23.61% | 22.82% | 22.27% | 23.03% | 22.93% | Upgrade
|
| D&A For EBITDA | 0.5 | 0.54 | 0.5 | 0.47 | 0.4 | Upgrade
|
| EBIT | 7.97 | 7.61 | 6.17 | 5.11 | 4.79 | Upgrade
|
| EBIT Margin | 22.22% | 21.32% | 20.61% | 21.10% | 21.15% | Upgrade
|
| Effective Tax Rate | 8.18% | 6.71% | 7.59% | 7.28% | 8.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.